
Pfizer Inc.
Add a review FollowOverview
-
Founded Date October 9, 1946
-
Sectors Accounting / Finance
-
Posted Jobs 0
-
Viewed 2
Company Description
New ‘discreet’ Viagra Launched ending Embarrassment Of Blue Pill
The makers of Viagra are set to launch a brand-new ‘discrete’ form of the drug that will replace the iconic – and quickly recognisable – little blue pill.
The unique diamond-shaped tablets could soon be replaced by a pink, rectangle-shaped ‘wafer’ that dissolves on the tongue, implying it does not require to be taken with water.
About half of males over 40 suffer erectile dysfunction in the UK and in 2015 there was a record 4.57 million prescriptions for Viagra on the NHS.
The drug first came to the market in the 1990s after being developed by the American pharmaceutical company Pfizer.
It was very first established in the 1980s as a heart problem medication, but trial participants noticed it had an unusual side effect – frequent erections.
Now, Pfizer spin-off Viatris, which owns the Viagra name and brand name, has made an application for a trademark in the UK for the brand-new kind of the drug, Viagra ODF.
Viatris has currently introduced the Viagra ODF in Canada and marketed it as being ‘thin and discreet’ which might be more effective for lots of customers.
The distinct tablets – which can cause shame for some clients – has been reinvented and a brand-new dissolvable type might be readily available to Brits in the next five years. Stock image
‘Tablets are not constantly bearable to patients and also often the size of tablets might put clients off having them,’ Thorrun Govind, pharmacist and health professional, told The Telegraph.
She included: ‘Some males might still be discovering the concept of having Viagr awkward, but I would hope that and conversations about sexual health have proceeded given that Viagra was first developed.’
Ms Govind thinks this new style is a ‘favorable advance’.
The new dissolvable medication is believed to most likely pertained to the UK imminently.
Rebecca Anderson-Smith, partner and chartered trade mark lawyer at Mewburn Ellis, told the newspaper that the trademark application is a ‘great indication’ it will be available within the next 5 years.
She explained trade mark registrations can be cancelled if they are not used for a continuous period of five years or more after registration. As an outcome, it appears Viatris means to launch the product within the next couple of years.
However, giving a trademark would not guarantee the ODF could be sold and it would need to be authorized by the Medicines & Healthcare items Regulatory Agency first.
It’s expected to cost the like the tablet version and to be offered in the very same dosages.
A total of 4.57 million prescriptions for sildenafil, more frequently understood by the brand Viagra, and other kinds of impotency drugs sold under the trademark name Cialis and Levitra, were dispensed by the health service in 2023
This comes after dodgy Viagra was found to be Britain’s greatest fake drug after more than ₤ 6.2 million of fake blue pill were taken by UK regulators in 2023.
More products of the erectile dysfunction drug were found than knock-off variations of painkillers like morphine.
Health authorities stated online sellers flouting regulations were behind the fake supplies with the majority of being imported from countries like India without a proper licence.
Data, from UK regulator The Medicines and Healthcare products Regulatory Agency (MHRA), show 2.6 million doses of sildenafil, the generic name for the medication best known as Viagra, were seized last year.
Another half-million dosages of tadalafil, another erectile dysfunction drug offered under the brand Cialis worth ₤ 1.2 million were also taken.
While all medications carry potential side impacts drugs from undependable sources might either not work or bring additional components or pollutants like heavy metals or other drugs that might be unsafe.